Buy 3 and get 1 for FREE
Dragon Pharma, Europe
CY3
Oral · 37 mcg/tab · 100 tabs
$34.00
Buy 3 and get 1 for FREE
Buy 5+ for $31.62 and save $11.90
Compound ID
Clenbuterol Hydrochloride / Liothyronine Sodium / Yohimbine Hydrochloride
Dosage
3.4–12.16 mg/day
Concentration
37 mcg Clenbuterol + 25 mcg Liothyronine + 5.4 mg Yohimbine
Form
100 tabs
Half-life
48–72 hours
Shipping
Not available in this combination
Product overview
Dragon Pharma CY3 — Triple-Compound Thermogenic for Contest-Ready Fat Loss
Dragon Pharma CY3 is an advanced oral fat burner combining three synergistic compounds in a single tablet: clenbuterol hydrochloride, liothyronine sodium, and yohimbine hydrochloride. Engineered for elite athletes facing stubborn adipose tissue, this metabolic stack attacks lipolysis through beta-2 receptor stimulation, thyroid hormone acceleration, and alpha-2 receptor blockade simultaneously. Each tablet delivers a precise 37mcg of clenbuterol, 25mcg of T3, and 5.4mg of yohimbine for multi-pathway thermogenic activity.
What is Dragon Pharma CY3?
This cutting agent is a pre-formulated thermogenic tablet containing a beta-2 agonist, an active thyroid hormone, and an alpha-2 antagonist. Unlike standalone fat burners that target a single metabolic pathway, this triple-compound design creates a cascading lipolytic effect.
Originally developed for advanced body recomposition, it is specifically indicated for the final stages of contest preparation or breaking through fat-loss plateaus where diet and cardio have stalled. The tablet format eliminates complex multi-product dosing while ensuring exact ratio consistency.
Key Benefits / Effects
- Multi-Pathway Thermogenesis: The beta-2 agonist elevates core temperature and metabolic rate, while the thyroid hormone accelerates cellular energy expenditure across all tissues, creating a powerful combined caloric deficit.
- Stubborn Fat Targeting: The alpha-2 antagonist specifically unlocks fat stores in resistant areas like the lower abdomen and hips by blocking receptors that normally inhibit lipolysis in these regions.
- Systemic Metabolic Overdrive: Liothyronine increases the basal metabolic rate of nearly every cell in the body, ensuring no adipose deposit remains unaffected by elevated energy turnover.
- Appetite Suppression: The stimulant properties of the beta-2 component reduce hunger signals, making strict caloric adherence more manageable during aggressive pre-contest restriction.
- Streamlined Dosing: The pre-mixed tablet eliminates the need to source, measure, and time three separate compounds individually, reducing protocol complexity.
- Bronchodilation: Improved oxygen transfer supports longer, more intense cardiovascular sessions, further accelerating energy expenditure during cutting phases.
How Dragon Pharma CY3 Works
Clenbuterol binds to beta-2 adrenergic receptors, activating adenylate cyclase and increasing cyclic AMP within adipocytes. This stimulates hormone-sensitive lipase, breaking down triglycerides into free fatty acids for oxidation.
Simultaneously, liothyronine enters cell nuclei and binds to thyroid hormone receptors, upregulating genes responsible for basal metabolic rate, mitochondrial density, and thermogenesis. This thyroid acceleration amplifies the caloric burn initiated by the beta-2 pathway.
Yohimbine completes the cascade by occupying alpha-2 adrenergic receptors on stubborn fat cells. Normally, these receptors actively block fat release. By antagonizing them, yohimbine removes the biological brake on lipolysis in resistant zones, allowing stored energy to enter the bloodstream.
Usage Information
This thermogenic tablet is supplied with each unit containing 37mcg clenbuterol, 25mcg liothyronine, and 5.4mg yohimbine. First-time users should begin with half a tablet for the first two to three days to assess tolerance.
The standard dose is one tablet daily, typically in the morning on an empty stomach. Advanced users with prior experience may increase to one tablet twice daily, though this significantly amplifies side effect risk. Due to beta-receptor desensitization, a mandatory two-week on, two-week off cycle is required. Do not exceed two tablets per day.
For maximum stubborn fat targeting, administer 30–60 minutes before fasted cardiovascular training. Avoid dosing after midday to prevent insomnia. A muscle-preserving anabolic base such as testosterone, Primobolan, or Anavar is mandatory to prevent T3-induced catabolism.
Quality & Manufacturing
Each tablet is manufactured under controlled conditions to ensure exact ratio consistency across all three active compounds. Precise dosing is critical because the interaction between thyroid hormone, beta-2 agonism, and alpha-2 blockade creates a narrow therapeutic window.
Pharmaceutical-grade tablet pressing guarantees uniform dissolution and predictable pharmacokinetics. In the thermogenic market, where ratio imbalances can produce dangerous cardiac stress or ineffective lipolysis, verified manufacturing ensures each tablet delivers the intended synergistic effect.
Possible Side Effects / Safety Information
- Cardiovascular Strain: The combined stimulant and thyroid effects can significantly elevate heart rate and blood pressure. Monitor resting pulse daily and discontinue if readings become excessive.
- Muscle Catabolism: The liothyronine component is profoundly catabolic and will break down lean tissue without adequate anabolic protection. A testosterone base or anti-catabolic agent is mandatory.
- Thyroid Suppression: Exogenous T3 can suppress natural thyroid production. A gradual taper and proper post-cycle transition help restore endogenous function.
- Stimulant Overload: Anxiety, tremors, insomnia, and excessive sweating are common. Avoid caffeine and other stimulants while using this product.
- Electrolyte Depletion: Taurine and potassium levels may drop, causing severe muscle cramps. Supplement 3–5 grams of taurine daily and consume electrolyte-rich foods.
- Hypoglycemia Risk: The metabolic acceleration may lower blood glucose. Fasted training requires caution, and some users benefit from small carbohydrate intake before intense sessions.
Why Choose Dragon Pharma CY3?
Pre-formulated triple-compound tablets eliminate the guesswork of manually stacking separate thermogenic agents. The precise ratio of beta-2 agonist, thyroid hormone, and alpha-2 antagonist is designed to work synergistically rather than redundantly.
For advanced athletes who have exhausted conventional fat-loss methods, this metabolic stack provides the multi-receptor pharmacology required to mobilize resistant adipose tissue. Pharmaceutical manufacturing ensures each tablet delivers the exact combination intended for extreme conditioning.
Greatest and fastest customer service I’ve seen. Haven’t gotten the product yet but I’ll write a review once I’ve received it
Product FAQ
Questions, answered
Most thermogenics target only beta-2 receptors or thyroid output individually. This tablet simultaneously stimulates beta-2 receptors, accelerates cellular metabolism through T3, and blocks alpha-2 receptors in stubborn fat zones. The combined effect creates a metabolic environment that single-pathway products cannot replicate.
Clenbuterol ignites thermogenesis and lipolysis. Liothyronine raises the metabolic rate of every tissue in the body. Yohimbine unlocks fat from resistant areas by blocking inhibitory receptors. Together they create a synchronized attack on stored body fat from multiple biochemical angles.
Begin with half a tablet daily for the first two to three days to assess tolerance. If no adverse cardiovascular or neurological effects occur, increase to one full tablet daily. Only experienced users should consider two tablets daily, and never exceed this amount.
The liothyronine component elevates metabolism indiscriminately and will catabolize muscle tissue in the absence of anabolic support. Without a testosterone base, Primobolan, or similar agent, users risk losing hard-earned lean mass alongside fat.
Exogenous liothyronine signals the hypothalamus to reduce TSH output, temporarily suppressing natural thyroid hormone production. A two-week cycling protocol and gradual transition off the product help the thyroid gland resume normal activity.
Take the first dose in the morning on an empty stomach, ideally 30–60 minutes before fasted cardio. This timing capitalizes on low insulin levels and maximizes yohimbine's ability to target stubborn fat. Avoid dosing after noon to prevent sleep disruption.
While fasted cardio enhances the alpha-2 antagonist's effect on stubborn fat, the product still produces significant thermogenesis and metabolic acceleration regardless of training timing. However, fasted morning administration remains the gold standard for optimal results.
Continuous use causes beta-2 receptor downregulation, rendering the clenbuterol component ineffective. The body also adapts metabolically to constant T3 exposure. The off period restores receptor sensitivity and prevents thyroid adaptation.
No. This is an advanced thermogenic stack intended for experienced athletes who have already used standalone clenbuterol or T3 and understand their individual tolerance. Beginners should start with milder single-compound alternatives.
The pre-formulated tablet ensures exact ratio consistency and eliminates the complexity of timing multiple separate products. The yohimbine addition specifically addresses stubborn fat, a component often overlooked in manual clenbuterol and T3 stacks.
Taurine at 3–5 grams daily is mandatory to prevent cramps. Potassium-rich nutrition supports electrolyte balance. A comprehensive anabolic base protects muscle tissue. Cardiovascular monitoring equipment is essential for safety.
The T3 component is highly catabolic. A testosterone base provides the anabolic signal necessary to preserve nitrogen retention and muscle protein synthesis. Without it, the metabolic acceleration will consume lean tissue as readily as fat stores.
